711b9145_tic_Goods_Administration__TGA__on_Medicines_Scheduling__ACMS__Scheduling_proposal
[Substance/s] Diclofenac [Scheduling proposal] 
Proposal to exempt from scheduling for diclofenac when presented as a 140 mg or less diclofenac transdermal drug delivery system.
Invitation for public comment - ACMS and ACCS meetings, March 2013 | Therapeutic Goods Administration (TGA)
Scheduling proposal